Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Steatosis and Fibrosis Measurements From Velacur and MRE/MRI-PDFF in Patients With Chronic Liver Disease

NCT05908006 is registered in ClinicalTrials.gov with GI Alliance as lead sponsor.

NCT NCT05908006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05908006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Steatosis and Fibrosis Measurements From Velacur and MRE/MRI-PDFF in Patients With Chronic Liver Disease
Lead sponsor
GI Alliance
Phase
Observational
Overall status
Unknown status
Start date
July 15, 2023
Completion date
January 31, 2024
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver disease (nafld)